ROCAPEN

This brand name is authorized in Nigeria.

Active ingredients

The drug ROCAPEN contains a combination of these active pharmaceutical ingredients (APIs):

`1`	Procaine benzylpenicillin UNII `17R794ESYN` - PENICILLIN G PROCAINE
	Read more about Procaine benzylpenicillin
`2`	Benzylpenicillin UNII `YS5LY7JF4N` - PENICILLIN G SODIUM
	Benzylpenicillin is a beta-lactam antibiotic. It is bacteriocidal by inhibiting bacterial cell wall biosynthesis. Penicillin resistance can be mediated by alteration of penicillin binding proteins or development of beta-lactamases.
	Read more about Benzylpenicillin

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J01CE30	Combinations	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01C Beta-lactam antibacterials, penicillins → J01CE Beta-lactamase sensitive penicillins
Discover more medicines within J01CE30

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	04-4034
Switch country to Nigeria in order to find specific presentations of ROCAPEN

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.